A retrospective trial assessing survival among adults diagnosed with Small Cell Lung Cancer in the U.S. from 2013-2021
Latest Information Update: 16 Sep 2022
At a glance
- Drugs Atezolizumab (Primary) ; Durvalumab (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 16 Sep 2022 New trial record
- 09 Aug 2022 Results presented at the 2022 World Conference on Lung Cancer